Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 9628455 | HLA (HLA) | myopathies | NA | NA | NA | unclassified | |
| hla allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. | |||||||
| 9628455 | HLA (HLA) | sporadic inclusion body myositis | NA | NA | NA | unclassified | |
| hla allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. | |||||||
| 9628455 | HLA-CLASS II (HLA CLASS II) | myopathies | NA | NA | NA | only_studied | |
| we studied the hla class ii associations in patients with sporadic inclusion body myositis (s-ibm) and hereditary inclusion body myopathies (h-ibm) and attempted to distinguish these myopathies on the basis of hla allele assignments. | |||||||
| 9628455 | HLA-CLASS II (HLA CLASS II) | sporadic inclusion body myositis | NA | NA | NA | only_studied | |
| we studied the hla class ii associations in patients with sporadic inclusion body myositis (s-ibm) and hereditary inclusion body myopathies (h-ibm) and attempted to distinguish these myopathies on the basis of hla allele assignments. | |||||||
| 23851103 | HLA-DRB1*11 | myopathies | NA | NA | NA | unclassified | |
| unlike other necrotizing myopathies, statin-induced myopathy is associated with the presence of autoantibodies directed against 3-hydroxy-3-methylglutaryl- coenzyme a reductase (the enzyme target of statin therapies), and with human leukocyte antigen-drb1*11. | |||||||
| 15496200 | HLA-DR3 (BROAD ANTIGEN) | sporadic inclusion body myositis | Caucasian | NA | NA | unclassified | |
| two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with hla-dr3. | |||||||
| 15496200 | HLA-A*01 | sporadic inclusion body myositis | Caucasian | NA | NA | unclassified | |
| previous studies of sporadic inclusion body myositis (sibm) have shown a strong association with hla-dr3 and other components of the 8.1 ancestral haplotype (ah) (hla-a1, b8, dr3), where the susceptibility locus has been mapped to the central major histocompatibility complex (mhc) region between hla-dr and c4. | |||||||
| 15496200 | HLA-DR3 (BROAD ANTIGEN) | sporadic inclusion body myositis | Caucasian | NA | NA | unclassified | |
| previous studies of sporadic inclusion body myositis (sibm) have shown a strong association with hla-dr3 and other components of the 8.1 ancestral haplotype (ah) (hla-a1, b8, dr3), where the susceptibility locus has been mapped to the central major histocompatibility complex (mhc) region between hla-dr and c4. | |||||||
| 16564169 | MHC (MHC) | sporadic inclusion body myositis | Japanese | NA | NA | unclassified | |
| sporadic inclusion body myositis in japanese is associated with the mhc ancestral haplotype 52.1. | |||||||
| 16564169 | HLA-B*35 | sporadic inclusion body myositis | Japanese | NA | NA | unclassified | |
| in caucasians, sporadic inclusion body myositis has been associated with the mhc ancestral haplotypes; hla-a1, b8, dr3 (8.1ah) and hla-b35, dr1 (35.2ah). | |||||||
Copyright 2024